Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 1 to 15 of 21 results for extracorporeal membrane oxygenation

  1. ⁠Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adults

    In development Reference number: GID-IPG10432 Expected publication date:  15 October 2025

    Interventional procedures guidance
    In development

  2. Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) in adults in refractory cardiac arrest

    In development Reference number: GID-IPG10431 Expected publication date:  15 October 2025

    Interventional procedures guidance
    In development

  3. Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults

    In development Reference number: GID-IPG10411 Expected publication date:  15 October 2025

    Interventional procedures guidance
    In development

  4. Extracorporeal membrane oxygenation (ECMO) in postneonatal children (IPG38)

    Evidence-based recommendations on extracorporeal membrane oxygenation in postneonatal children. This involves connecting the child's internal circulation to an external blood pump and artificial lung.

    Interventional procedures guidance
    Published
    28 January 2004
    View recommendations

    Sections for IPG38

  5. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)

    Evidence-based recommendations on extracorporeal membrane oxygenation for severe acute respiratory failure in adults. This involves using a tube to carry blood from the right side of the heart and then pump it through an artificial lung where it picks up oxygen.

    Interventional procedures guidance
    Published
    27 April 2011
    View recommendations

    Sections for IPG391

  6. Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)

    Evidence-based recommendations on extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. This involves using an artificial lung to oxygenate the blood outside the body.

    Interventional procedures guidance
    Published
    27 March 2014
    View recommendations

    Sections for IPG482

  7. Draft agenda - IPAC: 14 August 2025

    11. Post consultation comments IP1071/2 - Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults...

  8. NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This should include clear documentation of patient selection and indications for the use of ECMO. Outcome measures should include survival, quality of life and neurological status.

    Question NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This...

    Research recommendation
    Published
    9 June 2015

  9. Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)

    NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .

    Medtech innovation briefing
    Published
    21 May 2020

  10. CentriMag for heart failure (MIB92)

    NICE has developed a medtech innovation briefing (MIB) on CentriMag for heart failure .

    Medtech innovation briefing
    Published
    18 January 2017

  11. Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (IPG695)

    Evidence-based recommendations on ex-situ machine perfusion for extracorporeal preservation of lungs for transplant. This involves using a machine to deliver an oxygenated solution to a donor lung and keep it at normal body temperature until it can be transplanted.

    Interventional procedures guidance
    Published
    26 May 2021
    View recommendations

    Sections for IPG695

  12. NICE encourages further research into the use of innovative technologies for the management of severe acute respiratory failure, and may review this guidance on publication of further evidence.

    explanatory notes(if applicable) Evidence on the safety of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory...

    Research recommendation
    Published
    9 June 2015

  13. Extracorporeal carbon dioxide removal for acute respiratory failure (IPG776)

    Evidence-based recommendations on extracorporeal carbon dioxide removal for acute respiratory failure. This involves taking blood out of the circulatory system and passing it across a synthetic membrane that allows some of the carbon dioxide in the blood to be removed. The blood is then returned to the circulatory system.

    Interventional procedures guidance
    Published
    15 November 2023
    View recommendations

    Sections for IPG776

  14. What are the possible outcomes for people who are critically ill and have COVID-19-associated pulmonary aspergillosis (CAPA)?

    support (for example, invasive mechanical ventilation or extracorporeal membrane oxygenation [ECMO])• hospitalisation metrics (for...

    Research recommendation
    Published
    17 December 2021

  15. CytoSorb therapy for sepsis (MIB87)

    NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .

    Medtech innovation briefing
    Published
    29 November 2016